Jiangxi Synergy Pharmaceutical Co Ltd (300636) — Capital Reinvestment Ratio
Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a Capital Reinvestment Ratio of 1.49x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥65.40 Million) in capital expenditures (CN¥97.21 Million). Check 300636 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangxi Synergy Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Jiangxi Synergy Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Jiangxi Synergy Pharmaceutical Co Ltd.
Annual Capital Reinvestment Ratio for Jiangxi Synergy Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Jiangxi Synergy Pharmaceutical Co Ltd from 2013 to 2025. See how much free cash does Jiangxi Synergy Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.44x | CN¥202.07 Million | CN¥291.24 Million | ▲ +201.1% |
| 2024 | 0.48x | CN¥285.19 Million | CN¥136.49 Million | ▼ -63.5% |
| 2023 | 1.31x | CN¥163.75 Million | CN¥214.65 Million | ▼ -17.5% |
| 2022 | 1.59x | CN¥196.00 Million | CN¥311.49 Million | ▼ -50.8% |
| 2021 | 3.23x | CN¥131.34 Million | CN¥424.67 Million | ▲ +12.6% |
| 2020 | 2.87x | CN¥80.07 Million | CN¥229.99 Million | ▼ -11.2% |
| 2018 | 3.23x | CN¥74.93 Million | CN¥242.37 Million | ▼ -4.3% |
| 2017 | 3.38x | CN¥34.05 Million | CN¥115.11 Million | ▲ +607.5% |
| 2016 | 0.48x | CN¥60.45 Million | CN¥28.88 Million | ▼ -51.7% |
| 2015 | 0.99x | CN¥79.42 Million | CN¥78.53 Million | ▲ +104.2% |
| 2014 | 0.48x | CN¥64.50 Million | CN¥31.24 Million | ▼ -79.6% |
| 2013 | 2.37x | CN¥14.42 Million | CN¥34.20 Million | — |